Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wolters Kluwer Health unit buys iCare EMR Software
iCare EMR integrates a simulated electronic medical record into a learning tool for students to prepare future nurses for the demands of the evolving healthcare climate in the
iCare EMR integrates a simulated electronic medical record into a learning tool for students to prepare future nurses for the demands of the evolving healthcare climate in the
Sera Laboratories has launched liver microsome products from over 12 species, including mouse, rabbit, monkey and chicken, and the researchers can choose from pure microsomes or S9 fractions,
Ablynx said this is the first development candidate emerging from the strategic alliance which the companies entered into in 2007, and will result in a EUR5m milestone payment
Additional clinical endpoints, including reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved. In the trial, Laquinimod was safe and well-tolerated. In
V-Go devices will be available in a preset basal rate to deliver 20, 30 or 40 Units of insulin in one 24-hour period (0.83 U/hr, 1.25U/hr or 1.67U/hr
In November 2008, Zealand Pharma out-licensed ZP1846 to Helsinn Healthcare, under which Helsinn Healthcare received a worldwide exclusive license to ZP1846 and assumed responsibility for all further development,
The drug substance batches for AVDESP, which have been developed by Malaysia’s biopharma CMO – Inno Biologics, will be used to conduct clinical trials after formulation of the
Currently the president of McKesson Medical-Surgical, a unit of McKesson Corp, Tyler will succeed John Figueroa, who has accepted the position of CEO of Omnicare. Tyler will report
Initially, the joint venture will focus on commercialising buccally delivered insulin with an appropriate partner. Additionally, the companies have evaluated the safety of the nanoparticles in tolerability, acute
The studies will focus on the parkinson’s-implicated protein alpha-synuclein. Amicus chief scientific officer David Lockhart said that they are honored to receive this grant from the MJFF, which